inflammation and cardiovascular disease ivus Search Results

Newer Diabetes Drug may decrease progression of Plaque Build-up

Rosiglitazone—a member of the thiazolidinedione class of diabetes drugs—did not meet its primary endpoint for reducing progression of plaque build-up in coronary arteries in a study comparing it with glipizide, according to research presented at the America Heart Association’s Scientific Sessions 2008. Results of The APPROACH Trial—Assessment on the Prevention of Progression by Rosiglitazone on […]